An evidence-based medicine review of lymphadenectomy extent for gastric cancer

American Journal of Surgery

Volumn 197, Issue 2, 2009, Pages 246-251

  Yang, Sun Hu ^a   Zhang, You Cheng ^a   Yang, Ke Hu ^a   Li, You Ping ^a,b   He, Xiao Dong ^a   Tian, Jin Hui ^a   Lv, Ting Hong ^a   Hui, Ying Hua ^a   Sharma, Neel ^c  

^a LANZHOU UNIVERSITY   (China)

^b Chinese Cochrane Center   (China)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

D1, D2, D3; Gastric neoplasm; Meta analysis; Randomized controlled trials

Indexed keywords

CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GASTRECTOMY; HOSPITALIZATION; HUMAN; LYMPHADENECTOMY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH CANCER;

EVIDENCE-BASED MEDICINE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 58649084389     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.05.001     Document Type: Review

References (51)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Cady B. Lymph node metastases: indicators, but not governors of survival. Arch Surg 119 (1984) 1067-1072
3. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 11 (1981) 127-139
4. Kunisaki C., Shimada H., Yamaoka H., et al. Significance of para-aortic lymph node dissection in advanced gastric cancer. Hepatogastroenterology 46 (1999) 2635-2642
5. Takahashi S. Study of para-aortic lymph node metastasis of gastric cancer subjected to superextensive lymph node dissection. Nippon Geka Gakkai Zasshi 91 (1990) 29-35
6. Kitamura M., Arai K., and Iwasaki Y. Clinico-pathological studies and problems on para-aortic lymph node dissection-D4 dissection. Nippon Geka Gakkai Zasshi 97 (1996) 302-307
7. Isozaki H., Okajima K., Fujii K., et al. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 46 (1999) 549-554
8. Baba M., Hokita S., Natsugoe S., Miyazono T., et al. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 47 (2000) 893-896
9. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma (1995), Kanehara, Tokyo
10. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1 (1998) 10-24
11. Kunisaki C., Shimada H., Yamaoka H., et al. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepatogastroenterology 47 (2000) 586-589
12. Hsu C.P., Wu C.C., Chen C.Y., et al. Clinical experien in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 114 (1997) 544-551
13. Maeta M., Yamashiro H., Saito H., et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 125 (1999) 325-331
14. McCulloch P., Nita M.E., Kazi H., et al. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 18 (2004) CD001964
15. Bonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995) 745-748
16. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial-the Surgical Cooperative Group. Lancet 347 (1996) 995-999
17. In: Higgins J.P.T., and Green S. (Eds). Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Library (2006), Wiley, Chichester, UK Issue 4
18. http://www.cc-ims.net/RevMan/current.htm.
19. Petitti D.B. Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis (2000), Oxford University Press, New York
20. Bonenkamp J.J., Sasako M., Hermans J., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
21. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79 (1999) 1522-1530
22. Degiuli M., Sasako M., Calgaro M., et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30 (2004) 303-308
23. Liu J., Xu G., Zhuang D., et al. Comparison of the therapeutic effects of D1 to D2 operative methods in gastric cancer. Chin J Bas Clin Gener Surg 8 (2001) 169-170
24. Bunt A.M.G., Hermans J., Smit V.T., et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 13 (1995) 19-25
25. Dent D.M., Madden M.V., and Price S.K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75 (1988) 110-112
26. Bonenkamp J.J., van de Velde C.J., Sasako M., et al. R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomized trial. Eur J Surg 158 (1992) 413-418
27. Wu C.W., Hsiung C.A., Lo S.S., et al. Randomized clinical study of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 91 (2004) 283-287
28. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7 (2006) 309-315
29. Robertson C.S., Chung S.C., Woods S.D., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220 (1994) 176-182
30. Kodera Y., Sasako M., Yamamoto S., et al. Identification of risk factors for the development of complications following extended and superextended lymphadenectomy for gastric cancer. Br J Surg 92 (2005) 1103-1109
31. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 22 (2004) 2767-2773
32. Maeta M., Yamashiro H., Saito H., et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 125 (1999) 325-331
33. Kulig J., Popiela T., Kolodziejczyk P., et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193 (2007) 10-15
34. Yonemura Y., Wu C.C., Fukushima N., et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 53 (2006) 389-394
35. Jing B.J., Gao Y.F., Sun R.X., et al. Clinical study on the dissection of lmyph nodes around abdominal aortic artery in advanced gastric cancer. Chin J Gener Surg 9 (2000) 292-295
36. Yoshikawa T., Sasako M., Sano T., et al. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial. Br J Surg 93 (2006) 1526-1529
37. Wu C.W., Chang I.S., Lo S.S., et al. Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World J Surg 2006;30:12-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Whang%2DPeng+J%22%5BAuthor%5D
38. Wu C.W., Hsiung C.A., Lo S.S., et al. Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries. Eur J Surg Oncol 31 (2005) 153-157
39. Hartgrink H.H., van de Velde C.J., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit?. Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22 (2004) 2069-2077
40. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 84 (1997) 1567-1571
41. Jakab F., Baranyai L., Baranyai Z., et al. Lymphadenectomy in gastrointestinal surgery for malignancy. Acta Chir Hung 36 (1997) 141-142
42. Sasako M., Maruyama K., Kinoshita T., et al. Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer. Jpn J Clin Oncol 22 (1992) 41-48
43. Tsujinaka T., Sasako M., Yamamoto S., et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol 14 (2007) 355-361
44. Kasakura Y., Mochizuki F., Wakabayashi K., et al. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res 103 (2002) 252-259
45. Bunt T.M., Bonenkamp H.J., Hermans J., et al. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer 73 (1994) 1544-1551
46. Bunt A.M., Hermans J., Boon M.C., et al. Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 12 (1994) 417-422
47. Roukos D.H., Paraschou P., and Lorenz M. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7 (2000) 719-726
48. Chakrapan E., and Panuwat L. Results of D2 gastrectomy for gastric adenocarcinoma:10-year experience in Thai patients. J Med Assoc Thai 90 (2007) 291-300
49. http://www.cebm.net/index.aspx
50. Meakins J.L. Innovation in surgery: the rules of evidence. Am J Surg 183 (2002) 399-405
51. Lee J.H., Ryu K.W., Lee J.H., et al. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol 13 (2006) 1175-1181